Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

[Dying with living donor transplantation].

Reinhart W.

Ther Umsch. 2012 Dec;69(12):683-6. doi: 10.1024/0040-5930/a000349. German.

PMID:
23188779
2.

[Klatskin tumor. A study of 15 resected cases].

Santoro E, Sacchi M, Carboni F, Santoro R.

Chirurgie. 1999 Apr;124(2):132-9; discussion 139-40. Review. French.

PMID:
10349749
3.

Liver transplantation for primary sclerosing cholangitis.

Sekido H, Takeda K, Morioka D, Kubota T, Tanaka K, Endo I, Nagahori K, Togo S, Shimada H.

J Hepatobiliary Pancreat Surg. 1999;6(4):373-6. Review.

PMID:
10664284
4.

Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.

Duclos-Vallee JC, Sebagh M.

Liver Transpl. 2009 Nov;15 Suppl 2:S25-34. doi: 10.1002/lt.21916. Review.

5.

[Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors].

Beckurts KT, Hölscher AH, Bauer TH, Siewert JR.

Chirurg. 1997 Apr;68(4):378-84. Review. German.

PMID:
9206632
6.

Radical surgery for hilar cholangiocarcinoma.

Jonas S, Benckert C, Thelen A, Lopez-Hänninen E, Rösch T, Neuhaus P.

Eur J Surg Oncol. 2008 Mar;34(3):263-71. Epub 2007 Nov 26. Review.

PMID:
18042497
7.

Current therapy of hilar cholangiocarcinoma.

Lau SH, Lau WY.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):12-7. Review.

PMID:
22251465
8.

[Preoperative embolization of the portal vein in liver tumors].

Tarazov PG.

Vestn Khir Im I I Grek. 2001;160(1):117-21. Review. Russian. No abstract available.

PMID:
11258315
9.

Hilar cholangiocarcinoma: current management.

Ito F, Cho CS, Rikkers LF, Weber SM.

Ann Surg. 2009 Aug;250(2):210-8. doi: 10.1097/SLA.0b013e3181afe0ab. Review.

PMID:
19638920
10.

Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased?

Graziadei IW.

Curr Opin Gastroenterol. 2011 May;27(3):301-5. doi: 10.1097/MOG.0b013e3283437a8c. Review.

PMID:
21248637

Supplemental Content

Support Center